Companies / Pulse Biosciences, Inc. / Activity
Activity — Pulse Biosciences, Inc.
30 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | Robert W. Duggan Director | Buy | Common Stock | $13.00M | +660K +1.39% | 48,211,433 67.60% of shares | high |
| May 11, 2026 | Robert W. Duggan Director | Buy | Common Stock | $13.00M | +660K +1.38% | 48,370,047 67.82% of shares | high |
| Feb 11, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $504.0K | -20K -31.60% | 43,298 0.06% of shares | medium |
| Feb 17, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $472.6K | -20K -31.60% | 43,298 0.06% of shares | medium |
| Feb 13, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $470.6K | -20K -31.60% | 43,298 0.06% of shares | medium |
| Feb 10, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $470.4K | -20K -31.60% | 43,298 0.06% of shares | medium |
| Feb 12, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $467.4K | -20K -31.60% | 43,298 0.06% of shares | medium |
| Feb 9, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $429.0K | -20K -31.60% | 43,298 0.06% of shares | medium |
| May 11, 2026 | Laviolette Paul a CEO | Buy | Common Stock | $295.4K | +15K | 15,000 0.02% of shares | medium |
| May 11, 2026 | Laviolette Paul a CEO | Buy | Common Stock | $295.4K | +15K +1773.05% | 15,846 0.02% of shares | medium |
| Feb 18, 2026 | Danahy Kevin Patrick Executive | Sell | Common Stock | $118.2K | -5K -10.35% | 43,298 0.06% of shares | medium |
| Feb 17, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $30.6K | +20K +46.19% | 63,298 0.09% of shares | low |
| Feb 13, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $30.6K | +20K +46.19% | 63,298 0.09% of shares | low |
| Feb 12, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $30.6K | +20K +46.19% | 63,298 0.09% of shares | low |
| Feb 11, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $30.6K | +20K +46.19% | 63,298 0.09% of shares | low |
| Feb 10, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $30.6K | +20K +46.19% | 63,298 0.09% of shares | low |
| Feb 9, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $30.6K | +20K +46.19% | 63,298 0.09% of shares | low |
| Feb 18, 2026 | Danahy Kevin Patrick Executive | Exercise | Common Stock | $7.7K | +5K +11.55% | 48,298 0.07% of shares | low |
| Mar 23, 2026 | Uecker Darrin Executive | Grant | Restricted Stock Units | — | +100K | 100,000 0.14% of shares | low |
| Jun 11, 2026 | Robert W. Duggan Director | Grant | Stock Option (right to buy) | — | +12K | 12,495 0.02% of shares | low |
| Jun 11, 2026 | Robert W. Duggan Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.04% of shares | low |
| Feb 18, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -5K -1.64% | 300,000 0.42% of shares | low |
| Feb 17, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -20K -6.15% | 305,000 0.43% of shares | low |
| Feb 13, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -20K -5.80% | 325,000 0.46% of shares | low |
| Feb 12, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -20K -5.48% | 345,000 0.48% of shares | low |
| Feb 11, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -20K -5.19% | 365,000 0.51% of shares | low |
| Feb 10, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -20K -4.94% | 385,000 0.54% of shares | low |
| Feb 9, 2026 | Danahy Kevin Patrick Executive | Exercise | Stock Option (right to buy) | — | -20K -4.71% | 405,000 0.57% of shares | low |
| Feb 5, 2026 | Sainz Maria Director | Grant | Stock Option (right to buy) | — | +3K | 3,104 <0.01% of shares | low |
| Jan 8, 2026 | Sainz Maria Director | Grant | Stock Option (right to buy) | — | +50K | 50,000 0.07% of shares | low |